Clinical Trial Update: ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction [NA]

View source ↗

Summary

Clinical trial update indicates completion of a study evaluating zinc and clobetasol to prevent regorafenib-induced hand-foot skin reaction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Skin Reaction

Drugs mentioned

• Clobetasol (clobetasol)
• ZINC (Zinc chloride)

Snippet

Sponsor: Gazi University | Conditions: Hand-Foot Skin Reaction (HFSR) | NA | Status: COMPLETED